Siemens Healthineers AG
F:SHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Siemens Healthineers AG
F:SHL
|
DE |
|
VNET Group Inc
NASDAQ:VNET
|
CN |
|
C
|
CIMC Vehicles Group Co Ltd
HKEX:1839
|
CN |
|
F
|
FinTech Chain Ltd
ASX:FTC
|
HK |
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
M
|
Murray & Roberts Holdings Ltd
JSE:MUR
|
ZA |
Wall Street
Price Targets
SHL Price Targets Summary
Siemens Healthineers AG
According to Wall Street analysts, the average 1-year price target for
SHL
is 55.21 EUR
with a low forecast of 44.58 EUR and a high forecast of 66.36 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SHL's stock price target?
Price Target
55.21
EUR
According to Wall Street analysts, the average 1-year price target for
SHL
is 55.21 EUR
with a low forecast of 44.58 EUR and a high forecast of 66.36 EUR.
What is Siemens Healthineers AG's Revenue forecast?
Projected CAGR
5%
For the last 9 years the
compound annual growth rate for
Siemens Healthineers AG's revenue is
6%.
The projected
CAGR
for the next 3 years is
5%.
What is Siemens Healthineers AG's Operating Income forecast?
Projected CAGR
15%
For the last 9 years the
compound annual growth rate for
Siemens Healthineers AG's operating income is
5%.
The projected
CAGR
for the next 3 years is
15%.
What is Siemens Healthineers AG's Net Income forecast?
Projected CAGR
16%
For the last 9 years the
compound annual growth rate for
Siemens Healthineers AG's net income is
6%.
The projected
CAGR
for the next 3 years is
16%.
